Diabetes drug copycat put to the test in healthy volunteers
NCT ID NCT07633028
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study checked if a generic version of a diabetes combination pill (empagliflozin/metformin) works the same as the brand-name version in the body. 42 healthy adults took a single dose of each pill under fed conditions. The goal was to see if the two pills are bioequivalent, meaning they produce similar drug levels in the blood. This type of study helps ensure generic medicines are safe and effective alternatives.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIOEQUIVALENCE STUDY IN HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Axis Clinicals Latina, S.A. de C.V.
Mexico City, Mexico City, 07870, Mexico